etoposide has been researched along with epirubicin in 327 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (3.06) | 18.7374 |
| 1990's | 145 (44.34) | 18.2507 |
| 2000's | 111 (33.94) | 29.6817 |
| 2010's | 53 (16.21) | 24.3611 |
| 2020's | 8 (2.45) | 2.80 |
| Authors | Studies |
|---|---|
| Cole, SP; Deeley, RG; Grant, CE; Hipfner, DR; Loe, DW; Stride, BD | 1 |
| Dantzig, AH; Godinot, N; Iversen, PW; Perry, WL; Tabas, L; Williams, DC; Xia, X | 1 |
| Cole, SP; Deeley, RG; Grant, CE; Nunoya, K; Zhang, D | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anton, A; Aranda, E; Camps, C; Cervantes, A; Cruz Hernández, JJ; Díaz-Rubio, E; Dominguez, S; Dorta, J; Jimeno, J; Massuti, B | 1 |
| Ikami, I; Kanehira, J; Noda, H; Sasaki, T; Shibutani, K; Shinohara, A; Takahashi, S; Takekawa, D; Tarusawa, K; Yodono, H | 1 |
| Collard, P; Francis, C; Rodenstein, DO; Weynants, P | 1 |
| Alftan, H; Lehtovirta, P; Leminen, A; Stenman, UH | 1 |
| Abad, A; Barnadas, A; Carles, J; Haboubi, N; Jimeno, JM; Moreno, I; Ribelles, N; Rosell, R | 1 |
| Gatzemeier, U; Hossfeld, DK; Laumen, R; Lenaz, L; Neuhauss, R; Reck, M; von Pawel, J | 1 |
| Thongprasert, S | 1 |
| Nyman, CR | 1 |
| Piers, DA; Postmus, PE; Smit, EF | 1 |
| Cimoli, G; Conte, P; Conzi, G; Noviello, E; Orengo, G; Pagnan, G; Parodi, S; Russo, P; Schenone, F; Venturini, M | 1 |
| Bamberga, M; Bamberga, P; Gritti, G; Michetti, G; Ori-Belometti, M; Sarti, E; Villa, R | 1 |
| Beltrami, V; Bianco, AR; Ferrante, G; Gentile, M; Gridelli, C; Iacobelli, S; Irtelli, L; Martino, T; Natoli, C; Rossi, A | 1 |
| Shiu, WC | 1 |
| Akiyama, M; Inoue, Y; Sumiyoshi, Y; Yokota, K | 1 |
| Kingston, J; Malpas, J; McElwain, TJ; Meller, S; Mott, M; O'Brien, ME; Pinkerton, CR; Radford, M; Tait, D | 1 |
| Cold, S; Pfeiffer, P; Rose, C | 1 |
| Biscottini, B; Cellerino, R; Fatati, G; Guidi, F; Isidori, P; Raspugli, M; Tummarello, D | 1 |
| Angeletti, CA; Balbarini, A; Del Tacca, M; Macchiarini, P; Mariani, M; Mariotti, R; Mengozzi, G; Palagi, C; Petronio, AS; Squartini, F | 1 |
| Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP | 1 |
| Bastion, Y; Coiffier, B; Tigaud, JD | 1 |
| Astone, A; Barone, C; Cassano, A; Fontana, T; Garufi, C; Grieco, A; Noviello, MR; Pacelli, F; Ricevuto, E | 1 |
| Hausamen, TU; Loeffler, TM; Weber, FW | 1 |
| Angeletti, CA; Basolo, F; Bruno, J; Hardin, M; Macchiarini, P | 1 |
| Angeletti, CA; Bevilacqua, G; Chella, A; Ducci, F; Macchiarini, P; Rossi, B; Testi, C | 1 |
| Itoh, A; Oguro, A; Okano, S; Sawai, K; Takahashi, T; Takeuchi, K; Taniguchi, H; Tsukuda, N; Ueshima, Y | 1 |
| Akiyama, M; Sumiyoshi, Y; Yokota, K | 1 |
| Bolis, G; Borello, C; Maggi, R; Presti, M; Scarfone, G; Zanaboni, F | 1 |
| Eich, F; Emser, W; Sybrecht, GW | 1 |
| Blotta, A; Boltri, B; Busutti, L; Casadio, M; Falcone, F; Giordani, S; Lelli, G; Pannuti, F; Ramini, R | 1 |
| Angeletti, CA; Chella, A; Macchiarini, P; Mengozzi, G; Riva, A; Silvano, G; Solfanelli, S | 1 |
| Brandwein, JM; Callum, J; Keating, A; Scott, JG; Sutcliffe, SB | 1 |
| Cole, SP; Gerlach, JH; Mirski, SE | 1 |
| Caliceti, U; Guaraldi, M; Martoni, A; Occhiuzzi, L; Pannuti, F; Romagnoli, D; Rossi, AP | 1 |
| Boneschi, V; Brambilla, L; Clerici, M; Fossati, S; Melotti, E | 1 |
| Adamo, V; Alafaci, E; Altavilla, G; Buemi, B; Caristi, N; Condemi, G; Toscano, G | 1 |
| Beauduin, M; Bosly, A; Delaunois, L; Duprez, P; Francis, C; Gailly, C; Humblet, Y; Machiels, J; Majois, F; Weynants, P | 1 |
| Smeets, J; Utama, I; Wils, J | 1 |
| Biscottini, B; Cellerino, R; Fatati, G; Guidi, F; Isidori, P; Porfiri, E; Raspugli, M; Tummarello, D | 1 |
| Casadio, M; Giordani, S; Giuliotti, C; Lelli, G; Martoni, A; Pannuti, F; Strocchi, E | 1 |
| Grönroos, M; Kangas, L; Mäenpää, J | 1 |
| Ogawa, M | 1 |
| Mukaiyama, T; Ogawa, M | 1 |
| Berenson, RJ; Brugger, W; Heimfeld, S; Henschler, R; Kanz, L; Mertelsmann, R | 1 |
| Bonfante, V; Castellani, MR; Devizzi, L; Negretti, E; Santoro, A; Soncini, F; Villani, F; Viviani, S; Zanini, M; Zucali, R | 1 |
| Hendrick, A | 1 |
| Brugger, W; Frommhold, H; Kanz, L; Mertelsmann, R; Pressler, K | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A | 1 |
| Bertini, M; Botto, B; Freilone, R; Gavarotti, P; Levis, A; Orlandi, E; Orsucci, L; Pini, M; Pizzuti, M; Vitolo, U | 1 |
| Chiba, T; Fujioka, T; Hiura, M; Murakami, J; Nogawa, T; Shigemasa, K; Shimokawa, T; Yokoyama, T | 1 |
| Brandi, M; De Lena, M; Ditonno, P; Lorusso, V; Marzullo, F; Pellecchia, A; Timurian, A; Ventrella, V | 1 |
| Dercksen, MW; Dirkson, MK; Gerritsen, WR; Pinedo, HM; Rodenhuis, S; Schaasberg, WP; Slaper-Cortenbach, IC; van der Schoot, CE; von dem Borne, AE | 1 |
| Fichtner, I; Goan, SR; Herrmann, F; Just, U; Karawajew, L; Krause, KP; Schultze, W; von Harsdorf, S; von Schilling, C | 1 |
| Fujimoto, A; Ishihara, O; Itoyama, S; Kinoshita, K; Saitou, M; Takeda, S | 1 |
| Fujihara, M; Kyo, T; Myoken, Y; Sugata, T | 1 |
| Bertini, M | 1 |
| Adenis, A | 1 |
| Helmer, H; Kurz, C; Obermair, A; Pehamberger, K; Sevelda, P; Vavra, N | 1 |
| Biakhov, MIu; Buianov, SS; Dobrovol'skaia, NIu; Voznyĭ, EK | 1 |
| Fukunishi, H; Kitazawa, S; Takeuchi, S; Yukimura, N | 1 |
| Jassem, E; Jassem, J; Karnicka-Młodkowska, H; Malak, S; Moś-Antkowiak, R; Pilarska-Machowicz, A; Szymaczek-Meyer, L; Słupek, A; Wiatr, E; Zych, J | 1 |
| Cartei, G; Crivellari, D; Della Valentina, M; Foladore, S; Magri, MD; Nascimben, O; Sibau, A; Talamini, R; Trovò, MG; Veronesi, A | 1 |
| Catovsky, D; Cunningham, D; Gore, M; Hill, M; Horwich, A; Mansi, J; Milan, S; Selby, P; Smith, I; Zulian, G | 1 |
| Berchier, MC; Bureau, G; Giner, V; Kroll, F; Küstner, U; Michel, J; Mommen, P; Sculier, JP; Thiriaux, J; Van Cutsem, O | 1 |
| Bokemeyer, C; Dunn, T; Harstrick, A; Lerch, T; Poliwoda, H; Schmoll, HJ | 1 |
| Bader, GR; Costa, MA; Lamarca, JE | 1 |
| Chuchkova, M; Damianov, C; Koleva, P; Terziev, T | 1 |
| Higashida, T; Koishi, Y; Koyama, H; Masuyama, M; Miyata, K; Mugitani, T; Takeuchi, K; Tanaka, H; Taniguchi, H; Yamaguchi, T | 1 |
| Kobayashi, H; Obata, K | 1 |
| Battista, C; Bevilacqua, N; Chiurazzi, B; Cocorocchio, E; Esposito, G; Iodice, G; Pacilio, G; Panza, N | 1 |
| Ferrau, F; Guitart, J; Micali, G | 1 |
| de Jonge, A; Karim, AB; Meyer, OW; Njo, KH; Slotman, BJ | 1 |
| Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Ferrante, G; Gentile, M; Gridelli, C; Palmeri, S; Rossi, A; Veltri, E | 1 |
| Anania, C; Casaretti, R; Comella, G; Comella, P; Curcio, C; Daponte, A; Maiorino, A; Musetta, G; Scoppa, G | 1 |
| Bisail, M; Farris, A; Intini, C; Sanna, G; Sarobba, MG; Scotto, T; Valzelli, S | 1 |
| Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Gentile, M; Gridelli, C; Ianniello, GP; Maiorino, A; Palmeri, S; Pedicini, T | 1 |
| Connors, JM; Hoskins, P; Howdle, S; Klasa, R; Klimo, P; O'Reilly, SE; Stuart, DS | 1 |
| Denzlinger, C; Gerhartz, HH; Walther, J; Wilmanns, W | 1 |
| Chieco-Bianchi, L; Comis, S; Danova, M; Favaretto, A; Ghiotto, C; Giordano, M; Paccagnella, A; Panozzo, M; Pappagallo, G; Riccardi, A | 1 |
| Gerhartz, HH; Walther, J; Wilmanns, W | 1 |
| Ciavattini, A; Cignitti, M; De Nictolis, M; Garzetti, GG; Goteri, G; Romanini, C; Tranquilli, AL | 1 |
| Bajetta, E; Di Bartolomeo, M; Di Leo, A; Zampino, MG | 1 |
| Adamczyk-Cioch, MB; Dmoszyńska, A; Hus, I; Hus, M | 1 |
| Barrantes, JC; García, I; Lobo-Sanahuja, F; Santamaría, S | 1 |
| Falk, M; Fridrik, MA; Haidinger, R; Hausmaninger, H; Klocker, J; Linkesch, W; Neubauer, M; Pont, J; Radaszkiewicz, T; Raudaschl, G; Schiller, L; Seewann, HL; Sill, H; Stöger, M | 1 |
| Hasegawa, S; Koga, H; Kotoh, S; Kumazawa, J; Kuwano, M; Naito, S; Yokomizo, A | 1 |
| Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Frassoldati, A; Gobbi, PG; Lombardo, M; Pieresca, C; Silingardi, V; Vallisa, D | 1 |
| Arriagada, R; Le Chevalier, T; Le Péchoux, C | 1 |
| Curcio, C; D'Aprile, M; Gridelli, C; Ianniello, G; Lorusso, V; Palmeri, S; Palmieri, G; Perrone, F; Rossi, A; Veltri, E | 1 |
| Deguchi, S; Fujita, M; Honda, K; Kikuchi, T; Miyata, A | 1 |
| Avilés, A; Delgado, S; Díaz-Maqueo, JC; García, EL; Guzmán, R; Nambo, MJ | 1 |
| Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Kroll, F; Küstner, U; Lecomte, J; Michel, J; Mommen, P; Paesmans, M; Sculier, JP; Sergysels, R; Van Cutsem, O | 1 |
| Fujishiro, Y; Fuse, H; Katayama, T; Muraishi, Y | 1 |
| Haynes, AP; Iqbal, A; McQuaker, IG; Russell, NH | 1 |
| Fisch, P; Herbst, B; Köhler, G; Kulmburg, P; Lindemann, A; Mackensen, A; Mertelsmann, R; Rosenthal, FM; Schaefer, HE; Veelken, H | 1 |
| Akada, S; Anai, H; Hirohashi, S; Imai, T; Matsuo, N; Morikawa, H; Ohishi, H; Ohkura, A; Sakaguchi, H; Sakaguchi, S; Uchida, H | 1 |
| Gaarsdal, E; Jensen, L; Johnsen, HE; Knudsen, LM; Nielsen, KJ; Nikolaisen, K | 1 |
| Bertini, M; Botto, B; Cinieri, S; Ciotti, R; Di Nota, A; Di Vito, F; Freilone, R; Levis, A; Orsucci, L; Pini, M; Resegotti, L; Rota-Scalabrini, D; Todeschini, G; Vitolo, U | 1 |
| Charitopoulos, K; Dimitriadis, K; Economides, D; Maglaveras, N; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E | 1 |
| Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Bianco, AR; Curcio, C; D'Aprile, M; Gebbia, V; Gridelli, C; Palmeri, S; Pepe, R; Pistillucci, G; Rossi, A; Veltri, E | 1 |
| Bargou, R; Dörken, B; Hildebrandt, M; Körner, IJ; Krahl, D; Mapara, MY; Reichardt, P | 1 |
| Davey, MW; Davey, RA; Marks, DC; Su, GM | 1 |
| Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M | 2 |
| Leo, E; Lindemann, A; Schlegel, PG | 1 |
| Bardonnet-Comte, M; Berthaud, P; Chomy, F; Chomy, P; Douillard, JY; Gautier, V; Lagrange, JL; Le Chevalier, T; Milleron, B; Polin, V; Pujol, JL; Quoix, E; Rivière, A; Spaeth, D | 1 |
| Bessho, A; Harada, M; Higuchi, M; Miyamoto, T; Miyoshi, T; Ohno, Y; Omoto, E; Shinagawa, K; Sunami, K; Teshima, T; Ueoka, H | 1 |
| Ikeba, K; Kimura, M; Kinoshita, K; Maeda, H; Ohkubo, T; Sodemoto, T; Suwata, J; Suzuki, Y; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Anderson, S; Haynes, AP; McQuaker, IG; Russell, NH; Stainer, C | 1 |
| Athanassiou, A; Dimitriades, M; Kostopoulou, M; Mylonakis, A; Papadopoulou, M; Pectasides, D; Triantafillis, D; Varthalitis, J | 1 |
| Evans, TR; Gogas, H; Lofts, FJ; Mansi, JL; Millard, FJ; Wilson, R | 1 |
| Aikawa, K; Ishibashi, K; Koseki, K; Ogihara, M; Shiraiwa, Y; Yamaguchi, O | 1 |
| Bertz, H; Brugger, W; Fetscher, S; Kanz, L; Krieger, G; Lange, W; Mertelsmann, R | 1 |
| Fazeny, B; Fridrik, MA; Greil, R; Hausmaninger, H; Helm, W; Hudec, M; Klocker, J; Krieger, O; Neubauer, M; Oppitz, P; Pont, J; Radaszkiewicz, T; Simonitsch, I; Stöger, M | 1 |
| Etoh, Y; Imamura, H; Kamio, T; Nogami, T; Nomura, H; Saeki, T; Sakai, K; Suko, H; Suko, S; Tokunaga, H | 1 |
| Bertulezzi, G; Bobbio-Pallavicini, E; Civelli, L; Moroni, M; Nastasi, G; Porta, C; Pugliese, P | 1 |
| Sakata, Y; Tsushima, K | 1 |
| Hanazawa, T; Kimura, Y; Nagumo, M; Okano, T; Sakamaki, H; Yamaguchi, A | 1 |
| Balzarotti, M; Bonadonna, G; Bonfante, V; Camerini, E; Devizzi, L; Fornier, M; Santoro, A; Valagussa, P; Verderio, P; Viviani, S | 1 |
| Bacci, G; Bertoni, F; Briccoli, A; Campanacci, M; Cesari, M; Fabbri, N; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M | 1 |
| Astone, A; Barone, C; Cassano, A; Colloca, G; Corsi, DC; Fontana, T; Landriscina, M; Noviello, MR; Pozzo, C | 1 |
| Idezuki, Y; Inokuma, S; Ishizuka, N; Kobayashi, M; Maeda, H; Miura, T; Murata, N; Suwata, J; Takada, S | 1 |
| Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K | 1 |
| Badzio, A; Jassem, J; Jereczek-Fossa, B; Karnicka-Młodkowska, H; Kowal, E; Krawczyk, K; Malak, K; Moś-Antkowaik, R; Pilarska-Machowicz, A; Radzikowska, E | 1 |
| Folga, A; Fryze, W; Jassem, E; Mincewicz, H; Olszewska, A; Słomiński, JM | 1 |
| Chan, WK; Chao, Y; Chen, KY; Chen, SY; Chi, KH; Lee, SD; Lo, SS; Lui, WY; Wu, CW; Yen, SH | 1 |
| Blumenstengel, K; Fricke, HJ; Höffken, K; Kath, R; Kunert, C; Sayer, HG; Vogel, W | 1 |
| Biesma, B; Cox, A; Festen, J; Postmus, PE; Splinter, TA; Tjan-Heijnen, VC; Wagener, DJ | 1 |
| Iwasaki, M; Kudo, R; Mizumoto, H; Sagae, S; Terasawa, K | 1 |
| Avanzini, P; Baldini, L; Brugiatelli, M; Carotenuto, M; Clò, V; Di Renzo, N; Dini, D; Federico, M; Gobbi, PG; Lombardo, M; Silingardi, V; Vallisa, D | 1 |
| Callegaro, D; Fantoni, U; Favaretto, A; Festi, G; Loy, M; Paccagnella, A; Rea, F; Sartori, F | 1 |
| Akbulut, H; Aykan, F; Celik, I; Demirkazik, A; Firat, D; Içli, F; Ozet, A; Ozgüroğlu, M; Taş, F; Uner, A | 1 |
| Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S | 1 |
| Fountzilas, G; Kalofonos, C; Klouvas, G; Panoussaki, E; Pavlidis, N; Pectasides, D; Poulakis, N; Samantas, E; Skarlos, DV; Tsiakopoulos, E | 1 |
| Ashley, S; Atra, A; Kingston, JE; Mott, M; Pinkerton, CR; Shankar, AG | 1 |
| Downie, P; Ekert, H; Macfarlane, S; Smith, PJ; Toogood, I; White, L | 1 |
| Boher, JM; Daurès, JP; Grenier, J; Pujol, JL | 1 |
| Drag-Zalesińska, M; Gebarowska, E; Wysocka, T; Zabel, M | 1 |
| Gebarowska, E; Kołodziej, J; Majewski, A; Zabel, M | 1 |
| Borsellino, N; Colucci, G; Fortunato, S; Gebbia, N; Gebbia, V; Giuliani, F; Lelli, G; Lopez, M; Maiello, E; Testa, A | 1 |
| Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R | 2 |
| Daskalakis, A; Lange, W; Musahl, V; von Lintig, F; Waller, CF | 1 |
| Caramatti, C; Cesana, C; Garau, D; Mangoni, L; Regazzi, E; Rizzoli, V | 1 |
| Chang, WJ; Chen, CH; Liaw, CC; Tsao, TC; Yang, CT | 1 |
| Bargetzi, M; Heitzmann, F; Obeid, L; Schär, B | 1 |
| Byrne, J; Haynes, A; McQuaker, I; Russell, N; Stainer, C | 1 |
| Asano, M; Higashi, S; Hosono, Y; Kane, T; Kato, C; Matsumoto, K; Sakoda, M; Sakumoto, H; Sumiyoshi, K; Takahahsi, T; Takahashi, M; Yamamoto, A | 1 |
| Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P | 1 |
| Bisagni, G; Boni, C; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Morandi, P; Passalacqua, R; Savoldi, L; Zadro, A | 1 |
| Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
| Abate, G; Bianco, AR; Catalano, G; D'Aprile, M; Dammacco, F; De Lena, M; De Vita, F; Lauta, VM; Lorusso, V; Lucarelli, G; Mantovani, G; Marzullo, F; Palmieri, G; Polimeno, G | 1 |
| Anselmo, AP; Cavalieri, E; Enrici, RM; Funaro, D; Mandelli, F; Meloni, G; Pescarmona, E; Proia, A | 1 |
| Chang, FY; Chao, Y; Chi, KH; Hung, HC; King, KL; Li, CP; Teng, HC; Yen, SH | 1 |
| Heinz, R; Karlic, H; Mühlberger, H; Pavlova, B; Pfeilstöcker, M; Pittermann, E; Salamon, J; Strobl, H | 1 |
| Wils, J | 1 |
| Angrilli, F; Ascari, E; Bertè, R; Broglia, C; Cavanna, L; Di Renzo, N; Ghirardelli, ML; Gobbi, PG; Iannitto, E; Molica, S; Petrilli, MP | 1 |
| Fabian, A | 1 |
| Adwankar, MK; Juvekar, AS; Tongaonkar, HB | 1 |
| Giebel, S; Hołowiecki, J; Kachel, L; Kata, D; Krawczyk-Kuliś, M; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
| Ikeda, J; Takayasu, Y; Yamamoto, S | 1 |
| Angus, B; Carey, PJ; Finney, RD; Galloway, MJ; Goff, DK; Haynes, A; Jackson, GH; Lennard, AL; Leonard, RC; McQuaker, IG; Proctor, SJ; Russell, N; Taylor, PR; Windebank, K | 1 |
| Angelelli, B; Bovicelli, A; Ceccarelli, C; Costa, S; Erzén, M; Lipponen, P; Martoni, A; Santini, D; Syrjänen, K; Syrjänen, S; Terzano, P | 1 |
| Chan, JK; Cheung, MM; So, JC; Wong, KF | 1 |
| Artusi, T; Bonacorsi, G; Longo, L; Rivasi, F; Rossi, G | 1 |
| Herman, ZS; Machalski, M; Scieszka, M; Zielinski, M | 1 |
| Ponarska, A; Rogala, E; Rogińska, E; Rowińska-Zakrzewska, E; Szopiński, J | 1 |
| Angus, B; Carey, PJ; Conn, J; Culligan, D; Haynes, A; Iqbal, A; Jackson, GH; Lennard, AL; Leonard, RC; Lucraft, H; Proctor, SJ; Russel, N; Stark, A; Taylor, PR; Wood, K | 1 |
| Browne, PV; Daly, PA; Duggan, C; Enright, H; Gardiner, N; Kennedy, MJ; McCann, SR; O'Connell, N | 1 |
| Cady, J; de Gramont, A; Dehni, N; Lejeune, V; Louvet, C; Marpeau, L; Molitor, JL; Pigne, A; Sezeur, A; Tournigand, C | 1 |
| Ambrogi, M; Angeletti, CA; Basolo, F; Fontanini, G; Gunfiotti, A; Lucchi, M; Mussi, A | 1 |
| Takayasu, Y | 1 |
| Fischer, L; Foss, HD; Koch, HC; Korfel, A; Thiel, E | 1 |
| Dalrymple, C; Firth, I; MacLeod, C; O'Donnell, A; Tattersall, MH | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Neri, N; Talavera, A | 1 |
| Bielawski, K; Falkiewicz, B; Granetzny, A; Klinke, F; Vogt, U; Zaczek, A | 1 |
| Alloisio, M; Balzarotti, M; Bertuzzi, A; Castagna, L; Compasso, S; Nozza, A; Quagliuolo, V; Santoro, A; Siracusano, L; Soto Parra, H | 1 |
| Behr, W; Brockmeyer, C; Ehnle, S; Hempel, P; Müller, P; Oruzio, D; Riethmüller, R; Schlimok, G; Wochner, M | 1 |
| Chao, Y; Chen, LT; King, KL; Lan, C; Li, AF; Lin, WC; Liu, JM; Perng, CL; Tiu, CM; Whang-Peng, J | 1 |
| Alinari, L; Baccarani, M; Bonifazi, F; Gabriele, A; Molinari, AL; Salvucci, M; Stefoni, V; Tani, M; Tura, S; Zinzani, PL; Zuffa, E | 1 |
| Connolly, DL; Davis, RC; Hamaad, A | 1 |
| Davidson, A; Dick, G; Pinkerton, R; Pritchard-Jones, K | 1 |
| Johnson, DH | 1 |
| Aamdal, S; Aasebø, U; Boye, N; Bremnes, RM; Dahle, R; Hannisdal, E; Hatlevoll, R; Kaasa, S; Skovlund, E; Sundstrøm, S; Vigander, T; Vilsvik, J; Wang, M | 1 |
| Zinzani, PL | 1 |
| Angus, B; Jackson, GH; Lennard, A; Lucraft, HL; Proctor, SJ; Taylor, PR; White, J; Windebank, K; Wood, K | 1 |
| Bonfante, V; Fede Catania, A; Laffranchi, A; Maffioli, L; Villani, F; Viviani, S | 1 |
| Chang, MC; Chao, TY; Chen, LT; Chen, PJ; Cheng, AL; Hsiung, CA; Hsu, CH; Kao, WY; Su, IJ; Tien, HF; Tsao, CJ; Uen, WC; Whang-Peng, J | 1 |
| Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG | 1 |
| Brodak, M; Louda, M; Moravek, P; Odrazka, K; Petera, J; Prosvic, P; Rydel, L; Simakova, E; Vaculikova, M; Veselsky, Z; Zoul, Z | 1 |
| Erturk, D; Unsal, M | 1 |
| Chang, TT; Chang, WH; Chen, RL; Hsiao, TC; Hung, IJ; Lin, DT; Lin, KH; Lin, KS; Lin, MT; Lu, MY; Shu, SG; Wu, CT; Yang, CP; Yang, RS | 1 |
| Cady, J; de Gramont, A; Dehni, N; Fritel, X; Louvet, C; Milliez, J; Molitor, JL; Pigné, A; Sezeur, A; Tournigand, C | 1 |
| Bahrs, H; Gruber, Y; Kempgens, B; Kisro, J; Wagner, T | 1 |
| Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K | 1 |
| Daniel, PT; Dörken, B; Essmann, F; Geilen, CC; Müller, A; Schmelz, K; Schulze-Osthoff, K; Tamm, I; Wieder, T | 1 |
| Bertè, R; Bertini, M; Botto, B; De Paoli, A; Federico, M; Luminari, S; Merli, F; Mozzana, R; Pizzuti, M; Quintana, G; Stelitano, C; Trottini, M | 1 |
| Annunziata, M; Copia, C; D'Amico, MR; De Simone, M; Ferrara, F; Mele, G; Palmieri, S; Pocali, B; Schiavone, EM; Viola, A | 1 |
| Barone, C; Basso, M; Brunetti, IM; Cassano, A; D'Ugo, D; Longo, R; Persiani, R; Picciocchi, A; Pozzo, C; Schinzari, G | 1 |
| Baldinger, C; Fridrik, MA; Greil, R; Hausmaninger, H; Klocker, J; Krieger, O; Linkesch, W; Oberaigner, W; Pont, J | 1 |
| Alonso, C; Arrivi, A; Artal-Cortés, A; Barneto, I; Campbell, J; Camps, C; Carrato, A; Font, A; Garcia-Giron, C; Gomez-Codina, J; Gonzalez-Larriba, JL; Isla, D; Lomas, M; Maestu, I; Meana, A; Rosell, R; Vadell, C | 1 |
| Baek, JH; Kim, DH; Kim, JG; Lee, KB; Park, TI; Sohn, SK | 1 |
| Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P | 1 |
| Barone, C; D'Ugo, D; La Torre, G; Persiani, R; Picciocchi, A; Pozzo, C; Rausei, S; Ricci, R; Sermoneta, D | 1 |
| Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Seiter, K | 1 |
| Aamdal, S; Aasebø, U; Bremnes, RM; Kaasa, S; Sundstrøm, S | 1 |
| Ambrogi, MC; Angeletti, CA; Basolo, F; Duranti, L; Fontanini, G; Lucchi, M; Mussi, A | 1 |
| Fantini, M; Fattori, PP; Fochessati, F; Genestreti, G; Imola, M; Ioli, G; Lazzari-Agli, L; Mianulli, AM; Papi, M; Pasquini, E; Poggi, B; Ravaioli, A; Sartori, S; Tamburini, E; Tassinari, D | 1 |
| Agostini, V; Arcangeli, V; Fantini, M; Fattori, PP; Fochessati, F; Genestreti, G; Imola, M; Ioli, G; Mianulli, AM; Oliverio, G; Papi, M; Pasquini, E; Poggi, B; Ravaioli, A; Tamburini, E; Tassinari, D | 1 |
| Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N | 1 |
| Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Chamorey, E; Delwail, V; Fabbro, M; Foussard, C; Gressin, R; Harrousseau, JL; Lepeu, G; Maisonneuve, H; Peyrade, F; Richard, B; Rossi, JF; Thyss, A; Vilque, JP | 1 |
| Albarello, A; Ballerini, F; Balocco, M; Canepa, L; Canepa, P; Clavio, M; Garrone, A; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Varaldo, R | 1 |
| Dolezal, J; Dolezel, M; Moravek, P; Odrazka, K; Petera, J; Prosvic, P; Simakova, E; Vaculikova, M; Vosmik, M; Zoul, Z | 1 |
| Broglia, C; Corazza, GR; Federico, M; Gobbi, PG; Lambelet, P; Lombardo, M; Luminari, S; Mammi, C; Merli, F; Polimeno, G; Riezzo, A; Rovati, A; Valentino, F | 1 |
| Hiramatsu, Y; Hongo, A; Kodama, J; Nakamura, K; Ojima, Y; Seki, N | 1 |
| Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S | 1 |
| Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A | 1 |
| Baldini, E; Conte, PF; Del Freo, A; Fabbri, A; Falcone, A; Innocenti, F; Pennucci, MC; Prochilo, T; Russo, F; Tibaldi, C | 1 |
| Ambrosetti, A; Andreoli, A; Canal, F; Chilosi, M; Krampera, M; Lestani, M; Parolini, C; Pizzolo, G; Visco, C | 1 |
| Aurran, T; Biron, P; Bouabdallah, R; Boulat, O; Chabannon, C; Chetaille, B; Coso, D; Esterni, B; Gastaut, JA; Ivanov, V; Maraninchi, D; Rey, J; Schiano de Collela, JM; Sebban, C; Stoppa, AM; Xerri, L | 1 |
| Chan, GC; Cheuk, DK; Chiang, AK; Ha, SY; Lau, YL; Shek, TW | 1 |
| Biondi, A; Boccia, S; D'Ugo, D; Persiani, R; Rausei, S; Ricci, R; Vigorita, V | 1 |
| Fang, C; Song, MQ; Sun, Q; Wang, L; Zhu, JS; Zhu, L | 1 |
| Bishton, MJ; Haynes, AP | 1 |
| Abbott, BL; Chen, R; Myint, H | 1 |
| Al Harbi, T; Al-Faris, N; Doyle, J; Gassas, A; Goia, C; Pappo, A | 1 |
| Bishton, MJ; Byrne, JL; Haynes, AP; Lush, RJ; Russell, NH; Shaw, BE | 1 |
| Leonard, JP; Siegel, AB | 1 |
| Baldini, L; Bertini, M; Botto, B; Cabras, G; Di Vito, F; Federico, M; Gallo, E; Liberati, AM; Luminari, S; Marcheselli, L; Merli, F; Mozzana, R; Naglieri, E; Orsucci, L; Pennese, E; Polimeno, G; Vitolo, U | 1 |
| Andreesen, R; Blank, C; Hart, C; Hennemann, B; Krause, SW | 1 |
| Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Markaki, S; Papadimitriou, CA; Rodolakis, A; Voulgaris, Z; Zorzou, MP | 1 |
| Cartenì, G; Catalano, G; Ciardiello, F; Colucci, G; De Vita, F; Di Martino, N; Galizia, G; Gebbia, V; Giuliani, F; Maiello, E; Manzione, L; Montemurro, F; Orditura, M; Romito, S | 1 |
| Koizumi, K; Kondo, M; Minauchi, K; Mukai, M; Odani, T; Takada, A | 1 |
| Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
| Balzarotti, M; Isa, L; Magagnoli, M; Morenghi, E; Santoro, A; Siracusano, LV; Spina, M; Tirelli, U | 1 |
| Chang, HM; Kang, YK; Kim, KM; Kim, MK; Kim, TW; Lee, JL; Lee, JS; Lee, SS; Ryu, MH; Sym, SJ | 1 |
| Atzori, F; Catino, AM; Contu, A; Farris, A; Ionta, MT; Massidda, B; Minerba, L; Palmeri, S; Scanu, A | 1 |
| Lehoczky, O; Pulay, T | 1 |
| Angelucci, E; Baldini, L; Federico, M; Gavarotti, P; Gobbi, P; Iannitto, E; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Orsucci, L; Pavone, V; Ricardi, U; Ucci, G | 1 |
| Marik, PE; Vahid, B | 1 |
| Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
| Affolter, A; Ahmed, M; Marais, R; Nutting, CM; Pritchard-Jones, K; Sharma, AK; Thomas, V; Venkitaraman, R | 1 |
| Bishton, MJ; Fox, CP; Haynes, AP; McMillan, AK; Russell, NH | 1 |
| Csomor, J; Egyed, M; Egyházi, Z; Fekete, S; Kaszás, I; Kollár, B; Pajor, L; Timár, B | 1 |
| Barone, C; Biondi, A; Cananzi, FC; D'Ugo, D; Persiani, R; Pozzo, C; Rausei, S; Schinzari, G | 1 |
| Artal-Cortes, A; Barneto, I; Camps, C; Carrato, A; Gómez-Codina, J; González-Larriba, JL; Isla, D; Rosell, R; Safont, MJ; Sirera, R | 1 |
| Keller, U; Licht, T; Menzel, H; Müller, A; Peschel, C; Von Schilling, C | 1 |
| Gao, J; He, Z; Li, X; Li, Y; Liu, M; Tang, H; Wang, Q; Zheng, J | 1 |
| Brice, P; Casasnovas, O; Cazeneuve, C; Gabarre, J; Koscielny, S; Lenoir, G; Morschhauser, F; Ribrag, V; Salles, G; Stamatoullas, A | 1 |
| Andreesen, R; Grassinger, J; Hart, C; Hennemann, B | 1 |
| Kanz, L; Kopp, HG; Vogel, W; Weisel, KC; Yildirim, S | 1 |
| Nagai, T; Okubo, T; Sakaguchi, R; Seki, H; Takeda, S | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S | 1 |
| Borovskaya, TG; Gol'dberg, VE; Pachomova, AV; Perova, AV; Poluektova, ME | 1 |
| Fan, W; Jiang, Z; Shen, J; Sui, M; Wang, L; Xu, C | 1 |
| Bhartia, S; Proctor, SJ; Sieniawski, M; Wilkinson, J | 1 |
| Friberg, LE; Hansson, EK; Karlsson, MO; Lindman, H; Sandström, M; Wallin, JE | 1 |
| Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E | 1 |
| Arima, N; Hayashi, M; Nishimura, R; Okumura, Y; Osako, T | 1 |
| Capasso, I; Comella, G; Comella, P; D'Aiuto, G; D'Aiuto, M; Di Bonito, M; Frasci, G; Iodice, G; Lastoria, S; Montella, M; Oliviero, P; Petrillo, A; Ruffolo, P; Santangelo, M; Siani, C; Vizioli, L | 1 |
| Antonelli, A; Carpi, A; Cervetti, G; Fallahi, P; Franzoni, F; Galetta, F; Petrini, M; Regoli, F; Santoro, G; Tocchini, L | 1 |
| Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C | 1 |
| Arslan, C; Kilickap, S | 1 |
| Cai, JY; Chen, J; Dong, L; Jiang, H; Pan, C; Shen, SH; Tang, JY; Xu, M; Xue, HL; Ye, QD; Zhou, M | 1 |
| Ali, ZB; Ben Othmen, T; Bouaouina, N; Daoud, J; Elloumi, M; Ghannem, H; Laatiri, MA; Maalej, M; Meddeb, B; Msadek, F; Toumi, N | 1 |
| Bi, F; Lang, N; Liu, M; Liu, Z; Qiu, M; Tang, QL | 1 |
| Gallamini, A; Grimaldi, F; Nicolai, E; Pane, F; Picardi, M; Soricelli, A | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S | 1 |
| Guo, L; Han, X; Lang, J; Leng, J; Xiang, Y | 1 |
| Glimelius, B; Lahn, M | 1 |
| Al Nawakil, C; Beranger, N; Brice, P; Brière, J; de Bazelaire, C; de Kerviler, E; Ertault, M; Franchi, P; Sibon, D; Thieblemont, C | 1 |
| Cegovnik, U; Kern, I; Korošec, P; Košnik, M; Rijavec, M; Silar, M; Triller, N | 1 |
| Huang, DS; Liu, XC; Wu, YP; Yang, YP; Zhang, WL; Zhang, Y | 1 |
| Bonnabry, P; Fleury-Souverain, S; Geiser, L; Hochstrasser, D; Nussbaumer, S; Sadeghipour, F; Veuthey, JL | 1 |
| Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT | 1 |
| Cui, SD; Li, LF; Li, WL; Liu, H; Liu, ZZ; Lu, ZD; Yang, H; Zhang, HW | 1 |
| Guan, QL; Jiang, L; Mi, DH; Wang, J; Yang, KH | 1 |
| Cufer, T; Kern, I; Knez, L; Košnik, M; Ovčariček, T; Sadikov, A; Sodja, E | 1 |
| Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC | 1 |
| Dong, XJ; Li, LY; Wang, MZ; Xia, Y; Zhang, L; Zhang, XT; Zhao, J; Zhong, W | 1 |
| Cufer, T; Kern, I; Knez, L; Ovčariček, T; Sadikov, A; Sodja, E | 1 |
| Cao, J; Fan, C; Li, G; Li, N; Liu, S; Xu, J; Zhang, C | 1 |
| Austin, CA; Cowell, IG | 1 |
| Arnould, T; De Backer, O; Flamant, L; Hayez, A; Michiels, C; Pierre, M; Poumay, Y; Roegiers, E; Sterpin, C | 1 |
| Hao, J; Liu, GY; Wang, DH; Xu, YF; Yu, J; Yuan, BB | 1 |
| Bakalos, G; Doxani, C; Miligkos, M; Mpoulimari, I; Rodopoulou, P; Zintzaras, E | 1 |
| Elsing, C; Hannig, CV; Herrmann, C; Herrmann, T; Jäger, D; Stremmel, W | 1 |
| Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y | 1 |
| Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A | 1 |
| Bay, JO; Biron, P; Brindel, I; Bui, BN; Caty, A; de Revel, T; Delva, R; Dubot, C; Fizazi, K; Fléchon, A; Gaulet, M; Geoffrois, L; Gligorov, J; Gravis, G; Horn, E; Lotz, JP; Micléa, JM; Provent, S; Roubaud, G; Selle, F; Soares, DG; Temby, I; Wittnebel, S | 1 |
| Akahane, K; Fujii, M; Kawada, K; Murata, T; Oda, K; Ohama, T; Yatabe, Y | 1 |
| Adachi, S; Endo, I; Ichikawa, Y; Ishikawa, T; Kida, K; Narui, K; Sasaki, T; Satake, T; Shimada, K; Shimizu, D; Sugae, S; Tanabe, M; Yamada, A | 1 |
| Fukushima, T | 1 |
| Barlesi, F; Barre, P; Chatellain, P; Dayen, C; Derollez, M; Fournel, P; Herman, D; Jeannin, G; Lamy, PJ; Langlais, A; Lavole, A; Le Caer, H; Molinier, O; Morin, F; Moro-Sibilot, D; Mourlanette, P; Oster, JP; Pujol, JL; Quoix, E; Renault, A; Souquet, PJ; Zalcman, G | 1 |
| Brisse, H; Fasola, S; Mosseri, V; Orbach, D; Winter, S | 1 |
| Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
| Agama, K; Brünner, N; Doroshow, JH; Jensen, NF; Knudsen, BR; Pfister, TD; Pommier, Y; Roy, A; Rømer, MU; Smith, DH; Stenvang, J; Zhang, HL | 1 |
| He, Q; Ji, X; Li, G; Li, Y; Ma, L | 1 |
| Borovskaya, TG; Dygai, AM; Fomina, TI; Vychuzhanina, AV | 1 |
| Arima, N; Fukunaga, A; Hyuga, M; Iwasaki, M; Kishimoto, W; Maesako, Y; Nakae, Y | 1 |
| Chi, J; Lei, L; Li, T; Li, Z; Liu, P; Wang, J; Wang, X; Yan, H; Yang, B | 1 |
| Acramel, A; Chouquet, T; Faure, P; Goldwirt, L; Jourdan, N; Madelaine, I; Mourah, S; Plé, A; Sauvageon, H | 1 |
| Jantunen, E; Kuittinen, O; Peroja, P; Prusila, REI; Turpeenniemi-Hujanen, T | 1 |
| Li, J; Ping, P; Sun, Y; Xu, Y; Yao, C; Yin, H | 1 |
| Baker, J; Dexter, PR; He, J; Hui, SL; Jin, F; Kachroo, S; Shao, C; Zhang, Z | 1 |
| Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F | 1 |
| Kuittinen, O; Kuitunen, H; Tokola, S; Turpeenniemi-Hujanen, T | 1 |
| Chen, L; Chu, X; Liu, X; Wang, Y; Xu, L | 1 |
| Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
| Cruz, A; de-Castro-Ríos, A; Lema-Atán, JÁ; Lendoiro, E; López-Rivadulla, M; Paniagua-González, L | 1 |
| Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY | 1 |
| Wang, W; Wei, C; Zhang, W; Zhang, Y; Zhao, D; Zhou, D | 1 |
19 review(s) available for etoposide and epirubicin
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 1991 |
[Treatment strategy to obtain cure for recurrent advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Thiotepa | 1994 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
Burkitt's lymphoma involving the mandible: report of a case and review of Japanese cases.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Humans; Hydrocortisone; Japan; Male; Mandibular Neoplasms; Methotrexate; Prednisone; Soft Tissue Neoplasms | 1998 |
Chemotherapy of metastatic gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Humans; Leucovorin; Methotrexate; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2000 |
[Hepatic arterial infusion chemotherapy for hepatocellular carcinoma by EEP regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheters, Indwelling; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Treatment Outcome | 2001 |
Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Italy; Lymphoma, Non-Hodgkin | 2003 |
Toxicity of the topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases | 2005 |
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
Topics: Adenoma, Sweat Gland; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carcinoma, Acinar Cell; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Parotid Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survivors; Sweat Gland Neoplasms; Vincristine; Whole-Body Irradiation | 2008 |
[ALK-negative primary gastric anaplastic large cell lymphoma].
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Remission Induction; Salvage Therapy; Stomach Neoplasms; Transplantation, Autologous | 2007 |
Pulmonary complications of novel antineoplastic agents for solid tumors.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bevacizumab; Deoxycytidine; Doxorubicin; Epirubicin; Etoposide; Everolimus; Gemcitabine; Humans; Lung; Lung Diseases; Mitoxantrone; Neoplasms; Pneumonia; Pyrimidines; Risk Factors; Sirolimus; Teniposide; Trastuzumab | 2008 |
Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology.
Topics: Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Epirubicin; Etoposide; Humans; Melphalan; Molecular Targeted Therapy; Neoplasms; Topotecan | 2011 |
Cisplatin plus etoposide versus other platin-based regimens for patients with extensive small-cell lung cancer: a systematic review and meta-analysis of randomised, controlled trials.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Etoposide; Humans; Irinotecan; Lung Neoplasms; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Treatment Outcome | 2012 |
Assessing the relative effectiveness and tolerability of treatments in small cell lung cancer: a network meta-analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Randomized Controlled Trials as Topic | 2013 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Nitrosourea Compounds; Prednisolone; Prednisone; Prognosis; Salvage Therapy; Vincristine; Vindesine; Zidovudine | 2014 |
127 trial(s) available for etoposide and epirubicin
| Article | Year |
|---|---|
Etoposide (E) + epirubicin (E) + cisplatin (P) combination chemotherapy (EEP) in advanced gastric cancer: negative impact on clinical outcome. Spanish Cooperative Group for GI Tumor Therapy (T.T.D.).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Treatment Outcome | 1992 |
Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Etoposide; Feasibility Studies; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 1992 |
Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Recurrence; Thrombocytopenia; Time Factors; Vincristine | 1992 |
Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia | 1992 |
Cyclophosphamide, epirubicin, etoposide, cis platinum (CEVP) in combination with radiotherapy: evaluation of a protocol adopted for 6 years in 148 cases of small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1992 |
'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Vincristine | 1992 |
A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Radiotherapy; Survival Rate | 1991 |
Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Humans; Middle Aged; Stomach Neoplasms | 1991 |
Adjuvant chemotherapy for T1-2NOMO small cell lung cancer: single-agent or combination chemotherapy?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Vomiting | 1991 |
Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Recurrence | 1991 |
Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction | 1990 |
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Organoplatinum Compounds | 1989 |
Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC' versus no treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prospective Studies; Random Allocation | 1988 |
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Transfusion, Autologous; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Vincristine | 1994 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Risk Factors; Salvage Therapy; Vinblastine; Vincristine | 1994 |
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Survival Analysis | 1995 |
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisone; Prognosis; Remission Induction; Survival Rate; Vinblastine | 1994 |
CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
Topics: Actuarial Analysis; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Karnofsky Performance Status; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Treatment Failure; Vincristine | 1995 |
Therapeutic strategies in intermediate grade lymphomas in elderly patients. The Italian Multiregional non Hodgkin's Lymphoma Study Group (IMRNHLSG).
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Prednisone; Recombinant Proteins; Survival Analysis; Time Factors; Vinblastine | 1993 |
Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1994 |
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine | 1994 |
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fertility; Follow-Up Studies; Gonadotropins; Gonads; Hodgkin Disease; Humans; Male; Prednisolone; Sperm Count; Stroke Volume; Time Factors; Vincristine | 1995 |
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis | 1995 |
Phase II study of 4-epirubicin, etoposide and cisplatin as neoadjuvant chemotherapy in locally advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Etoposide; Female; Humans; Mastectomy; Middle Aged | 1994 |
Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunotherapy, Active; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednimustine; Urinary Bladder Neoplasms; Vinblastine | 1994 |
[Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Neoplasm Metastasis; Neoplasm Recurrence, Local; Preoperative Care; Stomach Neoplasms; Survival Rate | 1994 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Digestive System Diseases; Epirubicin; Etoposide; Humans; Kidney Diseases; Life Tables; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Survival Analysis | 1994 |
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging | 1994 |
Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vincristine | 1993 |
In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Probability; Prognosis; Prospective Studies; Treatment Outcome; Vincristine | 1993 |
Interleukin-3 enhances the endogenous leukotriene production.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Humans; Ifosfamide; Interleukin-3; Leukocyte Count; Leukotriene B4; Leukotrienes; Lymphoma; Recombinant Proteins | 1993 |
Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Count; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 1993 |
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Feasibility Studies; Female; Folic Acid; Hematologic Diseases; Humans; Ifosfamide; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1996 |
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Hemoglobins; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Vincristine | 1995 |
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged | 1995 |
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Europe; Female; Humans; Ifosfamide; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Remission Induction; Survival Rate; Vindesine | 1996 |
[Drug distribution of pelvic intraarterial infusion chemotherapy by bilateral internal iliac arterial catheter placement with coil occlusion of superior, inferior gluteal and obturator arteries].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Buttocks; Catheterization; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Middle Aged; Pelvic Neoplasms | 1996 |
The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bleomycin; Bone Marrow; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ketoconazole; Lymphoma, Non-Hodgkin; Male; Mycoses; Neoplasm Staging; Ofloxacin; Prednisone; Prognosis; Prospective Studies; Recombinant Proteins; Survival Rate; Vinblastine | 1996 |
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction | 1996 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cause of Death; Dose-Response Relationship, Drug; Drug Tolerance; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Thrombocytopenia | 1996 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Middle Aged; Palliative Care; Pneumonectomy; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Survival Analysis | 1997 |
Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Outpatients; Survival Rate | 1997 |
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphocyte Count; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neutropenia; Prednisolone; Recombinant Proteins; Vincristine | 1997 |
Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Survival Rate; Treatment Outcome | 1997 |
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Extremities; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis | 1998 |
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Indazoles; Leucovorin; Male; Middle Aged; Prognosis; Quality of Life; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 1998 |
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1998 |
Does chemotherapy-induced leukopenia predict a response in small-cell lung cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Leukocyte Count; Leukopenia; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Treatment Outcome; Vincristine | 1998 |
Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Survival Rate | 1998 |
Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Carmustine; Cell Separation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Ifosfamide; Macrophages; Male; Melphalan; Neoplasms; Prednisolone; Vincristine | 1998 |
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Heart Diseases; Hematologic Diseases; Humans; Idarubicin; Italy; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Stomach Neoplasms; Survival Analysis | 1998 |
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cranial Irradiation; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis | 1999 |
High incidence of treatment failure with vincristine, etoposide, epirubicin, and prednisolone chemotherapy with successful salvage in childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisolone; Prospective Studies; Salvage Therapy; Treatment Failure; Vincristine | 1999 |
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Stomach Neoplasms; Survival Analysis | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Survival Rate | 1999 |
Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Epirubicin; Erythropoietin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prospective Studies; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous | 1999 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1999 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Vincristine | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disseminated Intravascular Coagulation; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Stomach Neoplasms; Survival Rate | 2000 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
[Evaluation of nervous system disorders during the course of gastric carcinoma on the basis of clinical electrophysiologic analysis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Electrophysiology; Epirubicin; Etoposide; Evoked Potentials, Auditory; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Visual; Female; Fluorouracil; Humans; Male; Middle Aged; Nervous System Diseases; Paraneoplastic Syndromes; Stomach Neoplasms | 1999 |
Ifosfamide, etoposide, epirubicine, and G-CSF: an effective mobilization regimen for PBSCT in heavily pretreated patients.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma | 2000 |
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation Conditioning; Treatment Outcome | 2000 |
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; alpha Catenin; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Biomarkers, Tumor; Bleomycin; Cadherins; Carcinoma, Adenosquamous; Cisplatin; Cytoskeletal Proteins; Disease-Free Survival; Epirubicin; Etoposide; Female; Glycoproteins; Humans; Hyaluronan Receptors; Hysterectomy; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Survival Rate; Trans-Activators; Uterine Cervical Neoplasms | 2001 |
[The effect of small cell lung cancer extension on secretion of interleukin-2 (IL-2) and interferon gamma (IFM gamma) in whole blood culture stimulated with mitogens].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Etoposide; Female; Glucuronates; Humans; Ifosfamide; Interferon-gamma; Interleukin-2; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Remission Induction | 2001 |
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome | 2001 |
Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2001 |
Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Epirubicin; Epithelial Cells; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Parenteral; Laparotomy; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Postoperative Care; Second-Look Surgery | 2001 |
Treatment of refractory Hodgkin's disease with modified Stanford V program.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Survival Analysis; Vinblastine; Vincristine | 2001 |
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Mitoxantrone; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; Survival Analysis; Thiotepa; Vincristine | 2002 |
Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cisplatin; Creatine Kinase; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Immunotherapy; Middle Aged; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Survival Rate | 2000 |
Palliative MEFLEP therapy in advanced pancreatic cancer: excellent response in a patient with Her-2/neu amplification.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Gene Amplification; Humans; Leucovorin; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Receptor, ErbB-2 | 2002 |
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Quality of Life; Remission Induction; Survival Rate; Vincristine | 2002 |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Epirubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Risk Factors; Survival Analysis; Treatment Outcome; Virus Activation | 2003 |
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dexamethasone; Drug Administration Schedule; Epirubicin; Etoposide; Hormone Antagonists; Humans; Male; Middle Aged; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Saudi Arabia; Survival Rate; Vincristine | 2003 |
Unstratified chemotherapy for non-metastatic osteosarcoma of the extremities in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Statistics, Nonparametric; Survival Analysis; Taiwan; Treatment Outcome | 2003 |
Two schedules of application for mesna and their influence on the thiol-metabolism.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Mesna; Neoplasms; Protective Agents; Sulfhydryl Compounds | 2003 |
Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Appetite; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Pain; Prednisone; Quality of Life; Sleep; Surveys and Questionnaires; Vinblastine; Vincristine | 2004 |
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Glucuronates; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pilot Projects; Stomach Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2004 |
Long-term results of dose density therapy in patients with aggressive lymphoma.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Humans; Ifosfamide; Longitudinal Studies; Lymphoma; Mesna; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Failure; Treatment Outcome; Vincristine | 2005 |
Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cranial Irradiation; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Erythrocyte Transfusion; Etoposide; Female; Hospitalization; Humans; Lung Neoplasms; Male; Middle Aged; Platelet Transfusion; Prospective Studies; Radiotherapy, Adjuvant | 2004 |
Phase II study of cyclophosphamide,epirubicin, vincristine, prednisone, and etoposide (CEOP-E) for aggressive non-Hodgkin 's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2005 |
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine | 2005 |
Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cross-Over Studies; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Health Status; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Treatment Outcome; Vincristine | 2005 |
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine | 2005 |
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Pyruvaldehyde; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2006 |
Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Treatment Outcome; Uterus | 2007 |
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Treatment Outcome | 2006 |
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Rituximab; Survival Analysis; Transplantation, Autologous; Vincristine | 2006 |
[Immunoregulation and short-term therapeutic effects of super-selective intra-arterial chemotherapy combined with traditional Chinese drugs on gastric cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Synergism; Drug Therapy, Combination; Drugs, Chinese Herbal; Epirubicin; Etoposide; Female; Humans; Injections, Intra-Arterial; Interferon-gamma; Interleukin-2; Male; Middle Aged; Phytotherapy; Stomach Neoplasms; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Celiac Disease; Combined Modality Therapy; Cytarabine; Enteral Nutrition; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2007 |
Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Quality of Life; Survival Rate; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Stomach Neoplasms | 2007 |
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Portal Vein; Prospective Studies; Severity of Illness Index; Tablets, Enteric-Coated; Tegafur; Time Factors; Treatment Outcome; Uracil; Venous Thrombosis | 2007 |
Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Mastectomy; Mastectomy, Segmental; Middle Aged; Treatment Outcome | 2007 |
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Heart Diseases; Hodgkin Disease; Humans; Infections; Italy; Leukopenia; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vinblastine | 2008 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Gastrectomy; Glucuronates; Humans; Male; Middle Aged; Neoplasm Staging; Perioperative Care; Stomach Neoplasms; Survival Rate; Time Factors; Treatment Outcome | 2008 |
Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Epirubicin; Etoposide; Humans; Lung Neoplasms; Middle Aged; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2009 |
Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: analysis of remission induction and stem cell mobilization.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells.
Topics: Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Erythropoietin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Leukocyte Count; Leukocytes; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prospective Studies; Recombinant Proteins | 2009 |
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Recombinant Proteins; Survival Rate; Vincristine; Young Adult | 2010 |
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cisplatin; Combined Modality Therapy; Disease Progression; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Italy; Middle Aged; Paclitaxel; Preoperative Care; Taxoids | 2010 |
In vitro and in vivo study on the antioxidant activity of dexrazoxane.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bleomycin; Chromans; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Free Radical Scavengers; Glutathione; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Razoxane; Time Factors; Uric Acid; Vincristine | 2010 |
Results of RS-99 protocol for childhood solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Sarcoma, Ewing; Tamoxifen; Vincristine | 2010 |
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vinblastine | 2011 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2012 |
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine | 2012 |
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Thiotepa; Treatment Failure; Young Adult | 2014 |
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Etoposide; Female; France; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Small Cell Lung Carcinoma; Time Factors; Treatment Outcome; Young Adult | 2015 |
Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine | 2015 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
181 other study(ies) available for etoposide and epirubicin
| Article | Year |
|---|---|
Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Cells, Cultured; Culture Techniques; Drug Resistance, Neoplasm; Embryo, Mammalian; Estradiol; Glutathione; Humans; Isomerism; Kidney; Leukotriene C4; Membranes; Mice; Multidrug Resistance-Associated Proteins; Phenotype; Transfection; Vincristine | 1997 |
Cloning and functional characterization of the multidrug resistance-associated protein (MRP1/ABCC1) from the cynomolgus monkey.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Antibiotics, Antineoplastic; Cell Line, Transformed; Cloning, Molecular; Dogs; Drug Resistance, Multiple; Humans; Kidney; Leukotriene C4; Macaca fascicularis; Mice; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Species Specificity; Transfection | 2003 |
Molecular cloning and pharmacological characterization of rat multidrug resistance protein 1 (mrp1).
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Cell Line; Cloning, Molecular; DNA, Complementary; Doxorubicin; Embryo, Mammalian; Estradiol; Estradiol Congeners; Estrone; Gene Expression Regulation; Humans; Kidney; Leukotriene C4; Mice; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Species Specificity; Substrate Specificity; Transfection; Tritium | 2003 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Etoposide; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1992 |
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 1992 |
Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Middle Aged; Serpins; Trypsin Inhibitor, Kazal Pancreatic; Uterine Cervical Neoplasms | 1992 |
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vinblastine | 1992 |
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy with carboplatin, etoposide and epirubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Humans; Lung Neoplasms | 1992 |
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
Topics: Camptothecin; Cell Death; Cisplatin; DNA Damage; DNA, Neoplasm; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Mitomycin; Ovarian Neoplasms; Recombinant Proteins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage IIIA-IIIB non-small-cell lung cancer: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Treatment Outcome | 1992 |
Primary liver cancer in Hong Kong.
Topics: Adult; Aged; Epirubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1992 |
[Intra-arterial infusion chemotherapy of advanced bladder cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Male; Prognosis; Urinary Bladder Neoplasms | 1992 |
[The evaluation of the cardiotoxicity of 4'-epidoxorubicin at high doses].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Etoposide; Female; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardium | 1991 |
Pancreatoblastoma: response to chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine | 1991 |
Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Drug Stability; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Mesna; Middle Aged; Mitoxantrone; Neoplasms | 1991 |
Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Remission Induction; Thymoma; Thymus Neoplasms | 1991 |
[Clinical study of drug accumulation in gastric cancer after preoperative intra-arterial EAP II injection therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epirubicin; Etoposide; Female; Gastric Mucosa; Humans; Injections, Intra-Arterial; Lymph Nodes; Male; Preoperative Care; Stomach Neoplasms | 1991 |
[Intra-arterial infusion chemotherapy for advanced bladder cancer and prostate cancer using reservoir system].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1991 |
[Nerve conduction velocity following high-dose vincristine in the treatment of small cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Reaction Time; Synaptic Transmission; Vincristine | 1990 |
Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1990 |
Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Evaluation Studies as Topic; Hodgkin Disease; Humans; Male; Melphalan; Prednisone; Premedication; Remission Induction; Vincristine | 1990 |
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Topics: Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Line; Colchicine; Daunorubicin; Doxorubicin; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Epirubicin; Etoposide; Glycoproteins; Gramicidin; Humans; Immunosorbent Techniques; Isoxazoles; Lung Neoplasms; Menogaril; Mice; Mice, Inbred BALB C; Mitoxantrone; Nogalamycin; Phenotype; Vinblastine; Vincristine | 1987 |
Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Pilot Projects | 1988 |
Oral etoposide for Kaposi's Mediterranean sarcoma.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Sarcoma, Kaposi; Vinblastine | 1988 |
VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Procarbazine | 1989 |
Chemotherapy consisting of epirubicin, cisplatin, and etoposide followed by irradiation in stage III non-small cell lung cancer and chemotherapy alone in stage IV non-small cell lung cancer.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging | 1988 |
Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1986 |
Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Topics: Aclarubicin; Adolescent; Adult; Aged; Altretamine; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Methotrexate; Mice; Middle Aged; Mitomycins; Naphthacenes; Neoplasm Transplantation; Ovarian Neoplasms; Tegafur; Tumor Stem Cell Assay; Vincristine | 1985 |
[Current clinical status of new anticancer drugs].
Topics: Altretamine; Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Humans; Mitoxantrone; Neoplasms | 1983 |
Psychosis during interferon in eosinophilic leukaemia.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Delusions; Diagnosis, Differential; Epirubicin; Etoposide; Fatal Outcome; Hemibody Irradiation; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Immunologic Factors; Interferon-alpha; Leukemic Infiltration; Male; Palliative Care; Pruritus; Skin; Somatoform Disorders; Splenectomy; Vasculitis; Vincristine | 1994 |
[Study on peripheral blood stem cells mobilized by different chemotherapies with granulocyte-colony stimulating factor in ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Ovarian Neoplasms; Prednimustine | 1995 |
Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Marrow; Bone Marrow Cells; Carboplatin; Carmustine; Cell Adhesion Molecules; Cell Movement; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Fluorouracil; Gene Expression; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; L-Selectin; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Neutrophils; Platelet Count; Podophyllotoxin; Receptors, Very Late Antigen; Thiotepa | 1995 |
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis.
Topics: Adult; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Breast Neoplasms; Cell Line; Chimera; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fibroblasts; Fluorouracil; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Interleukin-3; Lymphoid Tissue; Male; Mice; Mice, SCID; Middle Aged; Ovarian Neoplasms; Rats; Severe Combined Immunodeficiency; Testicular Neoplasms; Transplantation, Heterologous | 1995 |
[A case of ovarian malignant Sertoli-Leidig cell tumor treated with CBDCA, etoposide and epirubicin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Remission Induction; Sertoli-Leydig Cell Tumor | 1995 |
Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report.
Topics: Acute Kidney Injury; Aged; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Epirubicin; Etoposide; Fatal Outcome; Fusarium; Gingival Diseases; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Maxillary Diseases; Mercaptopurine; Mycoses; Necrosis; Prednisolone; Ulcer; Vindesine | 1995 |
[Etoposide, epirubicin and cisplatin (EEP) combination in metastatic cancers of the cardia and the stomach. Groupe de recherche en cancérologie du Nord (GRECNO)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Treatment Outcome | 1994 |
Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fingers; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Nail Diseases; Ovarian Neoplasms; Toes | 1995 |
[Comparison of the effectiveness and toxicity of parenteral and oral vepesid in the treatment of disseminated breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Time Factors | 1995 |
Uterine myxoid leiomyosarcoma and CYVADIC-etoposide therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Epirubicin; Etoposide; Fatal Outcome; Female; Humans; Hysterectomy; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Mitotic Index; Treatment Outcome; Uterine Neoplasms; Vincristine | 1994 |
Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Division; Cell Line; Cisplatin; Doxorubicin; Drug Interactions; Drug Resistance; Epirubicin; Etoposide; Germinoma; Humans; Male; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Transplantation; Nifedipine; Testicular Neoplasms; Transplantation, Heterologous; Vinblastine | 1994 |
Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine; Vindesine | 1993 |
Merkel cell carcinoma of the scalp: dramatic resolution with primary chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Scalp; Skin Neoplasms | 1994 |
Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Lomustine; Lung Neoplasms; Methotrexate; Remission Induction; Survival Analysis; Thorax; Treatment Outcome; Vincristine | 1993 |
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate | 1994 |
IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Pilot Projects; Recombinant Proteins | 1993 |
Endometrioid carcinoma of the ovary. Retrospective study.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Endometriosis; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Retrospective Studies; Survival Rate; Tamoxifen | 1993 |
Epirubicin, etoposide and cisplatin in advanced pancreatic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1993 |
[Clinical and immunologic characteristics of CD 34 positive acute myeloid leukemia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Humans; Immunophenotyping; Leukemia, Myeloid; Male; Middle Aged; Remission Induction | 1995 |
Case report: pulmonary blastoma in children--response to chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Pulmonary Blastoma; Vincristine | 1996 |
Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Transitional Cell; Cisplatin; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Fluorouracil; Humans; Mitomycin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Selection, Genetic; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil; Vinca Alkaloids | 1995 |
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Humans; Lung Neoplasms | 1995 |
[Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Doxorubicin; Epirubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 1996 |
Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate | 1996 |
Etoposide, epirubicin and carboplatin in hormone-refractory prostate cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Castration; Drug Resistance; Epirubicin; Etoposide; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Survival Rate | 1996 |
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Lymphoma, Follicular; Male; Melphalan; Methotrexate; Podophyllotoxin; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1996 |
In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type.
Topics: Antigen Presentation; Antigens, CD; Antigens, CD34; Bone Marrow; Cell Differentiation; Cells, Cultured; Cisplatin; Cytoplasmic Granules; Dendritic Cells; Drug Synergism; Epirubicin; Epithelial Cells; Etoposide; Hematopoietic Stem Cells; HLA-DR Antigens; Humans; Ifosfamide; Immunophenotyping; Interleukin-3; Interleukin-4; Interleukin-6; Langerhans Cells; Lymph Nodes; Recombinant Proteins; Spleen; Stem Cell Factor; T-Lymphocyte Subsets; Tetanus Toxoid; Tumor Necrosis Factor-alpha | 1996 |
Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Blood Transfusion, Autologous; Bone Marrow; Carmustine; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Injections, Subcutaneous; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Recombinant Proteins | 1996 |
Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cisplatin; DNA, Complementary; DNA, Neoplasm; Epirubicin; ErbB Receptors; Etoposide; Evaluation Studies as Topic; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoenzyme Techniques; Immunomagnetic Separation; Keratins; Leukapheresis; Melphalan; Middle Aged; Neoplasm Proteins; Neoplastic Cells, Circulating; Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Transplantation Conditioning | 1997 |
Extended multidrug resistance in haemopoietic cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hematopoietic Stem Cells; HL-60 Cells; Humans; Leukemia, Myeloid; Paclitaxel; Tumor Cells, Cultured; Vinblastine | 1996 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine | 1997 |
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine | 1997 |
Circulating immature cell counts on the harvest day predict the yields of CD34+ cells collected after granulocyte colony-stimulating factor plus chemotherapy-induced mobilization of peripheral blood stem cell.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Cytarabine; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukocyte Count; Male; Middle Aged; Neoplasms | 1997 |
[Two cases of adenosquamous cell carcinoma of advanced cervical cancer treated by carboplatin-based chemotherapy with peripheral blood stem cell autotransplant].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Uterine Cervical Neoplasms | 1997 |
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide.
Topics: Adult; Aged; Cyclophosphamide; Drug Combinations; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Multivariate Analysis; Transplantation Conditioning | 1997 |
CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Palliative Care; Prognosis; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 1997 |
[Neoadjuvant intra-arterial chemotherapy based on chemosensitivity tests for locally invasive bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mitomycin; Peplomycin; Prognosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 1997 |
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leiomyosarcoma; Stomach Neoplasms | 1997 |
[A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Remission Induction; Stomach Neoplasms; Vincristine | 1997 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Receptors, Interleukin-2; Recurrence; Reference Values; Retrospective Studies; Vinblastine; Vincristine | 1998 |
[A case report of neoadjuvant intra-arterial injection chemotherapy combined with peripheral blood stem cell reinfusion in an advanced breast cancer patient].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Mastectomy, Radical | 1998 |
[A case of binocular blindness in small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Male; Paraneoplastic Syndromes | 1998 |
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Mesna; Prospective Studies; Recombinant Proteins; Vincristine | 1998 |
[Mobilization of peripheral blood stem cells in advanced ovarian cancer].
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Ovarian Neoplasms | 1998 |
Long term results of surgery and chemotherapy in small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Prospective Studies; Radiotherapy, Adjuvant; Survival Rate; Vincristine | 1998 |
A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Disease Progression; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Recurrence; Salvage Therapy; Vincristine | 1998 |
Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Humans; Keratin-19; Keratins; Lung Neoplasms; Markov Chains; Prognosis; Proportional Hazards Models; Prospective Studies; Tissue Polypeptide Antigen | 1999 |
Evaluation of apoptosis and necrosis induction in cultured cells of lung carcinomas under effect of cytostatic drugs in vitro.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Humans; Lung Neoplasms; Methotrexate; Necrosis; Tumor Cells, Cultured; Vinblastine; Vincristine | 1999 |
Evaluation of individual sensitivity to cytostatic drugs of in vitro cultured lung tumor cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Epirubicin; Etoposide; Fluorouracil; Lung Neoplasms; Methotrexate; Tumor Cells, Cultured; Vinblastine; Vincristine | 1999 |
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1999 |
Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Immunophenotyping; Leukapheresis; Leukocyte Count; Male; Neoplasms | 1999 |
The effects of two different cisplatin-based chemotherapy regimens on advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Survival Rate | 1999 |
[Burkitt's lymphoma--a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Methotrexate; Prednisone; Vincristine | 1999 |
Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease.
Topics: Adult; Antigens, CD34; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Stem Cell Transplantation; Stem Cells | 1999 |
Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Salvage Therapy; Survival Rate; Transplantation Conditioning; Transplantation, Autologous | 2000 |
Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Galpha 16 and CD34.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Epirubicin; Etoposide; Female; Gene Expression; GTP-Binding Protein alpha Subunits, Gq-G11; Hematopoiesis; Heterotrimeric GTP-Binding Proteins; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; RNA, Messenger; Time Factors | 2000 |
Effect of cisplatin-based chemotherapy on emergence of cisplatin resistance, and its correlation with intracellular glutathione levels and accumulation of p53 protein in human ovarian cancer.
Topics: Antineoplastic Agents; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Glutathione; Humans; Ovarian Neoplasms; Tumor Suppressor Protein p53 | 2000 |
[Hepatic arterial infusion chemotherapy using totally implantable port system].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin | 2000 |
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine | 2001 |
Primary high-grade mucosa-associated lymphoid tissue-type lymphoma of the cervix presenting as a common endocervical polyp.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Immunohistochemistry; In Situ Hybridization; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Neoplasm Proteins; Polyps; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2001 |
Quality of life in cancer patients treated by chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Colorectal Neoplasms; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Neoplasms; Quality of Life; Stomach Neoplasms; Surveys and Questionnaires | 2000 |
Thymic carcinoma: a report of 13 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Italy; Male; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Survival Rate; Thymoma; Thymus Neoplasms; Treatment Outcome | 2001 |
Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cell Differentiation; Cisplatin; Combined Modality Therapy; Diphosphonates; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Orchiectomy; Pamidronate; Remission Induction; Rhabdomyosarcoma; Seizures; Seminoma; Spinal Neoplasms; Teratoma; Testicular Neoplasms; Transplantation, Autologous | 2001 |
Locally advanced cervix cancer: chemotherapy prior to definitive surgery or radiotherapy. A single institutional experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Humans; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2001 |
p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; DNA Mutational Analysis; DNA, Complementary; DNA, Neoplasm; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Genes, p53; Humans; Lung Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Prognosis; Tumor Cells, Cultured | 2002 |
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2002 |
Regression of HTLV1 associated intracardiac lymphoma following chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Heart Neoplasms; Humans; Ifosfamide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisone; Remission Induction; Ultrasonography; Vincristine | 2002 |
EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)-chemotherapy selected for multidrug resistance modulation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Kidney Diseases; Male; Neoplasms; Vincristine | 2002 |
"The guard dies, it does not surrender!" progress in the management of small-cell lung cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Humans; Lung Neoplasms; Vincristine | 2002 |
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Management; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Salvage Therapy; Survival Rate; United Kingdom | 2003 |
Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Electrocardiography; Epirubicin; Etoposide; Female; Follow-Up Studies; Heart; Heart Function Tests; Hodgkin Disease; Humans; Lung; Male; Mediastinal Neoplasms; Middle Aged; Radiotherapy Dosage; Respiratory Function Tests; Retrospective Studies; Time Factors; Vincristine | 2003 |
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis | 2003 |
Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Remission Induction; Treatment Outcome | 2003 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health | 2004 |
Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Topics: Adult; Antineoplastic Agents; Apoptosis; bcl-X Protein; Blotting, Northern; Caspase 8; Caspases; Cell Death; Cell Line, Tumor; Ceramides; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hodgkin Disease; Humans; Intracellular Membranes; Leukemia, Myeloid; Membrane Potentials; Mitochondria; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sphingomyelins; Tumor Necrosis Factor-alpha | 2004 |
Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2004 |
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Gastrectomy; Humans; Laparoscopy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Care; Prognosis; Proportional Hazards Models; Stomach Neoplasms; Survival Rate | 2005 |
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Thymoma; Thymus Neoplasms; Treatment Outcome | 2005 |
Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2005 |
[Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies | 2005 |
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Multiple Myeloma; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy; Time Factors; Transplantation Conditioning; Treatment Outcome | 2005 |
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
Topics: Aged; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dexamethasone; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hormones; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome | 2005 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine | 2006 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine | 2007 |
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Cohort Studies; Cyclin-Dependent Kinase Inhibitor p21; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Genes, p53; Germinal Center; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Proteins; Phenotype; Prednisone; Prognosis; Radiotherapy, Adjuvant; Reproducibility of Results; Rituximab; Survival Analysis; Survival Rate; Tumor Suppressor Protein p53; Vincristine | 2006 |
Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Gastrectomy; Humans; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Stomach Neoplasms; Survival Rate | 2006 |
Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunction.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; HIV Infections; Humans; Liver Diseases; Male; Prednisone; Remission Induction; Vincristine | 2006 |
Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infection Control; Kaplan-Meier Estimate; Melphalan; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Postoperative Care; Retrospective Studies; Risk; Salvage Therapy; Sarcoma, Ewing; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Vincristine | 2007 |
Therapy for older patients with diffuse large cell lymphoma: targeting the treatment to the patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Autologous; Treatment Outcome | 2007 |
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Sarcoma; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 2007 |
High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Recurrence | 2007 |
Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies | 2008 |
[Evaluation of second-line chemotherapies most often used in recurrent epithelial ovarian cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Topotecan; Treatment Outcome | 2007 |
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Iodine Radioisotopes; Male; Neoplasms, Second Primary; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Thoracic Vertebrae; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2008 |
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2008 |
Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Prostatectomy; Prostatic Neoplasms; Rituximab; Survival | 2008 |
S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Calcium-Binding Proteins; Cell Proliferation; Epirubicin; Etoposide; Female; Fluorescent Antibody Technique; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Tumor Cells, Cultured | 2008 |
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Frequency; Glucuronosyltransferase; Hodgkin Disease; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Young Adult | 2009 |
Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma.
Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Survival Analysis; Syndecan-1; Transplantation, Autologous; Young Adult | 2009 |
Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome; Uterine Cervical Neoplasms | 2008 |
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult | 2009 |
The stage of offspring of female rats after treatment with cytostatics of various groups.
Topics: Animals; Carboplatin; Cisplatin; Cytostatic Agents; Drug Administration Schedule; Epirubicin; Etoposide; Female; Male; Paclitaxel; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Time Factors | 2008 |
The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Receptors, Progesterone; Steroids; Treatment Outcome; Vincristine | 2009 |
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Registries; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 2009 |
Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Count; Cell Enlargement; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Fluorouracil; Humans; Models, Biological; Myelopoiesis; Neoplasms; Neutrophils; Observation; Paclitaxel; Precision Medicine; Taxoids; Topotecan | 2010 |
Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Cell Proliferation; Cyclophosphamide; Docetaxel; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Ki-67 Antigen; Logistic Models; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Analysis; Tamoxifen; Taxoids; Tumor Suppressor Protein p53 | 2010 |
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2010 |
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Paclitaxel; Preoperative Care; Prognosis; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome | 2010 |
[Tunisian experience in the treatment of aggressive non Hodgkin's lymphoma in adults: about 337 patients].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Analysis; Tunisia; Vincristine; Young Adult | 2010 |
Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
Topics: AC133 Antigen; Antibiotics, Antineoplastic; Antigens, CD; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Fluorouracil; Glycoproteins; Humans; Hyaluronan Receptors; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organoplatinum Compounds; Oxaliplatin; Peptides; Vincristine | 2010 |
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contrast Media; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Liver; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Recurrence; Spleen; Tomography, X-Ray Computed; Young Adult | 2011 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult | 2010 |
Vaginal adenosarcoma arising from refractory endometriosis: a case report.
Topics: Adenofibroma; Adenosarcoma; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Endometriosis; Epirubicin; Etoposide; Female; Gestrinone; Humans; Hysterectomy; Ifosfamide; Membrane Proteins; Ovariectomy; Salpingectomy; Treatment Outcome; Vaginal Neoplasms; Vincristine | 2010 |
Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prospective Studies; Real-Time Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine | 2011 |
[Mobilization and collection of autologous peripheral blood stem cells by CIE or IEV protocol in children with malignant solid tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Male; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Rhabdomyosarcoma; Transplantation, Autologous | 2011 |
Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.
Topics: Antineoplastic Agents; Camptothecin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Epirubicin; Etoposide; Gemcitabine; Ifosfamide; Irinotecan; Methotrexate; Organophosphorus Compounds; Surface Properties; Tandem Mass Spectrometry; Vincristine | 2012 |
[Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Taxoids; Technetium Tc 99m Sestamibi | 2011 |
Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cisplatin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Gene Frequency; Genotype; Haplotypes; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Small Cell Lung Carcinoma; Vincristine | 2012 |
[Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myelopoiesis; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Small Cell Lung Carcinoma; Survival Rate | 2012 |
Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Epirubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Proteins; Pilot Projects; Prognosis; Retrospective Studies; Single-Blind Method; Slovenia; Topotecan; Treatment Outcome; Vincristine | 2012 |
Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Routes; Epirubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intra-Arterial; Injections, Intravenous; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Stomach Neoplasms; Survival Rate | 2012 |
Do transcription factories and TOP2B provide a recipe for chromosome translocations in therapy-related leukemia?
Topics: Anthracyclines; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Etoposide; Humans; Leukemia; Mitoxantrone; Models, Genetic; Neoplasms, Second Primary; Poly-ADP-Ribose Binding Proteins; Translocation, Genetic | 2012 |
TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Kaplan-Meier Estimate; Keratinocytes; Liver Neoplasms; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcriptome | 2012 |
[Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Fluorouracil; Gene Knockdown Techniques; Humans; Inhibitory Concentration 50; Nocodazole; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Polyploidy; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Small Interfering; Taxoids; Vincristine | 2012 |
Sequential chemotherapies for advanced gastric cancer: a retrospective analysis of 111 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Germany; Hospitals, University; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Retrospective Studies; Salvage Therapy; Stomach Neoplasms; Taxoids; Treatment Outcome | 2013 |
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Multidisciplinary management of small cell carcinoma of the breast: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Ultrasonography, Mammary | 2014 |
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Mammaplasty; Mastectomy, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Perforator Flap; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Young Adult | 2015 |
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.
Topics: Benzodioxoles; Binding Sites; Camptothecin; Cell Line, Tumor; Chromosome Deletion; Colonic Neoplasms; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Gene Dosage; Guanidines; HCT116 Cells; HT29 Cells; Humans; Hydrazones; Irinotecan; Isoquinolines; Mutation | 2016 |
Application of FLEEOX Preoperative Chemotherapy via Intra-arterial and Intravenous Administration in Treatment of Unresectable Locally Advanced Gastric Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Prognosis; Remission Induction; Stomach Neoplasms; Survival Rate | 2016 |
Quantitative Evaluation of Primordial Follicles in Rat Ovaries during the Early and Delayed Terms after Different Cytostatic Exposures.
Topics: Animals; Carboplatin; Cisplatin; Cytostatic Agents; Epirubicin; Etoposide; Female; Ovarian Follicle; Ovary; Rats; Rats, Wistar | 2016 |
Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients.
Topics: Antigens, CD34; Antineoplastic Agents; Epirubicin; Etoposide; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cells; Prospective Studies; Salvage Therapy | 2016 |
Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
Topics: Autocrine Communication; Cell Line, Tumor; Cell Proliferation; Cell Survival; Epirubicin; Etoposide; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; Insulin-Like Growth Factor II; Models, Biological; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptor, IGF Type 2; Rhabdoid Tumor; Signal Transduction; SMARCB1 Protein; Stress, Physiological; Tumor Microenvironment | 2017 |
Mutagenicity assessment of environmental contaminations in a hospital centralized reconstitution unit.
Topics: Anthracyclines; Antineoplastic Agents; Chromatography, Liquid; Cyclophosphamide; Doxorubicin; Environmental Monitoring; Environmental Pollution; Epirubicin; Equipment Contamination; Etoposide; Hospitals; Irinotecan; Mutagenicity Tests; Salmonella typhimurium; Tandem Mass Spectrometry | 2018 |
Treatment of diffuse large B-cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP-16).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Substitution; Epirubicin; Etoposide; Female; Follow-Up Studies; Heart Diseases; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Matched-Pair Analysis; Prednisone; Progression-Free Survival; Retrospective Studies; Rituximab; Vincristine | 2019 |
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
Topics: Cyclophosphamide; Doxorubicin; Drug Stability; Epirubicin; Etoposide; Humans; Infusion Pumps; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Vindesine | 2019 |
Survival, Chemotherapy Treatments, and Health Care Utilization Among Patients with Advanced Small Cell Lung Cancer: An Observational Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Medicare; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome; United States | 2020 |
Evaluation of ovarian reserve before and after chemotherapy.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Female; Fertility Preservation; Fluorouracil; Hodgkin Disease; Humans; Longitudinal Studies; Luminescent Measurements; Ovarian Reserve; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult | 2021 |
Interim and end-of-treatment PET-CT suffers from high false-positive rates in DLBCL: Biopsy is needed prior to treatment decisions.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Clinical Decision-Making; Confidence Intervals; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; False Positive Reactions; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prednisone; Proportional Hazards Models; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2021 |
Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Glucocorticoids; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Rituximab; Treatment Outcome; Vincristine | 2022 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |
LC-MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure.
Topics: Chromatography, Liquid; Cyclophosphamide; Cytostatic Agents; Epirubicin; Etoposide; Gemcitabine; Humans; Irinotecan; Occupational Exposure; Paclitaxel; Tandem Mass Spectrometry; Vinorelbine | 2023 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; Pancreas; Pancreatic Neoplasms; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2022 |
Long-time follow-up of patients with untreated peripheral T cell lymphoma following chidamide combined with cyclophosphamide, epirubicin, vindesine, prednisone, and etoposide therapy: a single-center propensity score-matching study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Propensity Score; Retrospective Studies; Vincristine; Vindesine | 2023 |